What question did this study set out to answer?

The research aims to enhance the control of liposome size in drug delivery through a machine learning approach integrated with process analytical technology.

May 3, 2026

Liposome Particle Size Prediction by In-Line Process Analytical Technology (PAT)-Integrated Machine Learning.

Key Points

The research aims to enhance the control of liposome size in drug delivery through a machine learning approach integrated with process analytical technology.
Developed a predictive machine learning model using in-line PAT data.
Integrated physicochemical membrane characteristics for model training.
Evaluated model accuracy with a root mean square error of 7.18 nm.
Achieved 7.18 nm accuracy in predicting liposome particle size with limited data.
The model generalization yielded a root mean square error of 7.53 nm.
Establishes a practical framework for advanced control of liposome sizes.

Abstract

Precise control of liposome size is critical for drug delivery. We developed an in-line PAT-integrated machine learning model that predicts particle size with high accuracy (root mean square error 7.18 nm) using limited experimental data. By integrating physicochemical membrane characteristics, the model demonstrates generalization (root mean square error 7.53 nm) and interpretability, establishing a practical framework for advanced liposome particle size control.

Liposome Particle Size Prediction by In-Line Process Analytical Technology (PAT)-Integrated Machine Learning.

Key Points

Abstract

Cite This Study